Publications

2024

• Chronological vs Biological Age in Interventional Cardiology: A Comprehensive Approach to Care for Older Adults: JACC Family Series.Damluji AA, Nanna MG, Rymer J, Kochar A, Lowenstern A, Baron SJ, Narins CR, Alkhouli M. Chronological vs Biological Age in Interventional Cardiology: A Comprehensive Approach to Care for Older Adults: JACC Family Series. JACC Cardiovasc Interv 2024, 17: 961-978. PMID: 38597844, DOI: 10.1016/j.jcin.2024.01.284.
• Noninvasive Ventilation in the Cardiac Intensive Care Unit.Schenck CS, Chouairi F, Dudzinski DM, Miller PE. Noninvasive Ventilation in the Cardiac Intensive Care Unit. J Intensive Care Med 2024, 8850666241243261. PMID: 38571399, DOI: 10.1177/08850666241243261.
• Frailty and In-Hospital Outcomes for Management of Cardiogenic Shock without Acute Myocardial Infarction.Park DY, Jamil Y, Ahmad Y, Coles T, Bosworth HB, Sikand N, Davila C, Babapour G, Damluji AA, Rao SV, Nanna MG, Samsky MD. Frailty and In-Hospital Outcomes for Management of Cardiogenic Shock without Acute Myocardial Infarction. J Clin Med 2024, 13 PMID: 38610842, DOI: 10.3390/jcm13072078.
• Reporting Use of AI in Research and Scholarly Publication—JAMA Network GuidanceFlanagin A, Pirracchio R, Khera R, Berkwits M, Hswen Y, Bibbins-Domingo K. Reporting Use of AI in Research and Scholarly Publication—JAMA Network Guidance. JAMA 2024, 331: 1096-1098. PMID: 38451540, DOI: 10.1001/jama.2024.3471.
• Association of cardiovascular diseases with cognitive performance in older adults.Park DY, Jamil Y, Babapour G, Kim J, Campbell G, Akman Z, Kochar A, Sen S, Samsky MD, Sikand NV, Frampton J, Damluji AA, Nanna MG. Association of cardiovascular diseases with cognitive performance in older adults. Am Heart J 2024, 273: 10-20. PMID: 38575050, DOI: 10.1016/j.ahj.2024.03.016.
• Derivation of an Annualized Claims-Based Major Adverse Cardiovascular Event Estimator in Type 2 DiabetesMcCoy R, Swarna K, Deng Y, Herrin J, Ross J, Kent D, Borah B, Crown W, Montori V, Umpierrez G, Galindo R, Campana J, Mickelson M, Polley E. Derivation of an Annualized Claims-Based Major Adverse Cardiovascular Event Estimator in Type 2 Diabetes. JACC Advances 2024, 3: 100852. DOI: 10.1016/j.jacadv.2024.100852.
• COVID-19−Associated Acute Kidney Injury and Longitudinal Kidney OutcomesAklilu A, Kumar S, Nugent J, Yamamoto Y, Coronel-Moreno C, Kadhim B, Faulkner S, O’Connor K, Yasmin F, Greenberg J, Moledina D, Testani J, Wilson F. COVID-19−Associated Acute Kidney Injury and Longitudinal Kidney Outcomes. JAMA Internal Medicine 2024, 184: 414-423. PMID: 38407862, PMCID: PMC10897825, DOI: 10.1001/jamainternmed.2023.8225.
• The Role of the Clinical Psychologist in the Care of Adults With Cardiovascular DiseaseSmolderen K, Gillaspy S, Evers A, Kovacs A, Massa-Carroll I, Moons P, Mena-Hurtado C. The Role of the Clinical Psychologist in the Care of Adults With Cardiovascular Disease. JACC Advances 2024, 3: 100910. DOI: 10.1016/j.jacadv.2024.100910.
• LDL Receptor-Related Protein 5 Selectively Transports Unesterified Polyunsaturated Fatty Acids to Intracellular CompartmentsTang W, Luan Y, Yuan Q, Li A, Chen S, Menacherry S, Young LH, and Wu D; Nature Communications
• Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasiaWang D, Ito S, Waldron C, Butt A, Zhang E, Krumholz H, Al-Samkari H, Goshua G. Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood Advances 2024 PMID: 38537061, DOI: 10.1182/bloodadvances.2024012589.
• Neonatal Outcomes are Similar between Patients with Resolved and Those with Persistent OligohydramniosWhelan A, Has P, Savitz D, Danilack V, Lewkowitz A. Neonatal Outcomes are Similar between Patients with Resolved and Those with Persistent Oligohydramnios. American Journal Of Perinatology 2024 PMID: 38423121, DOI: 10.1055/a-2278-8948.
• Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunitiesStroope C, Nettersheim F, Coon B, Finney A, Schwartz M, Ley K, Rom O, Yurdagul A. Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities. Nature Metabolism 2024, 1-22. PMID: 38532071, DOI: 10.1038/s42255-024-01015-w.
• Clinical spectrum of Transthyretin amyloidogenic mutations among diverse population originsDe Lillo A, Pathak G, Low A, De Angelis F, Abou Alaiwi S, Miller E, Fuciarelli M, Polimanti R. Clinical spectrum of Transthyretin amyloidogenic mutations among diverse population origins. Human Genomics 2024, 18: 31. PMID: 38523305, PMCID: PMC10962184, DOI: 10.1186/s40246-024-00596-7.
• Frailty in the Cardiac Intensive Care Unit: Assessment and ImpactMoumneh M, Jamil Y, Kalra K, Ijaz N, Campbell G, Kochar A, Nanna M, van Diepen S, Damluji A. Frailty in the Cardiac Intensive Care Unit: Assessment and Impact. European Heart Journal Acute Cardiovascular Care 2024, zuae039. PMID: 38525951, DOI: 10.1093/ehjacc/zuae039.
• Clinical Physiology: The Crucial Role of MRI in Evaluation of Peripheral Artery DiseaseElsaid N, Peters D, Galiana G, Sinusas A. Clinical Physiology: The Crucial Role of MRI in Evaluation of Peripheral Artery Disease. AJP Heart And Circulatory Physiology 2024 PMID: 38517227, DOI: 10.1152/ajpheart.00533.2023.
• Abstract 3632: Cytokine profiles associated with ICI myocarditis using machine learning approaches identifies novel cytokines and implicated pathwaysChehayeb R, Hong D, Chen N, Martinez C, Jayakrishnan R, Guajardo A, Lin D, Im Y, Halene S, VanOudenhove J, Hwa J, Jha A, Kwan J. Abstract 3632: Cytokine profiles associated with ICI myocarditis using machine learning approaches identifies novel cytokines and implicated pathways. Cancer Research 2024, 84: 3632-3632. DOI: 10.1158/1538-7445.am2024-3632.
• Abstract 2480: Treatment of steroid-refractory immune checkpoint inhibitor-associated myocarditis: A case series of 18 patientsJayakrishnan R, Brongiel S, Luon D, Halene S, Kwan J. Abstract 2480: Treatment of steroid-refractory immune checkpoint inhibitor-associated myocarditis: A case series of 18 patients. Cancer Research 2024, 84: 2480-2480. DOI: 10.1158/1538-7445.am2024-2480.
• Dedifferentiated early postnatal lung myofibroblasts redifferentiate in adult diseaseChandran R, Adams T, Kabir I, Gallardo-Vara E, Kaminski N, Gomperts B, Greif D. Dedifferentiated early postnatal lung myofibroblasts redifferentiate in adult disease. Frontiers In Cell And Developmental Biology 2024, 12: 1335061. PMID: 38572485, PMCID: PMC10987733, DOI: 10.3389/fcell.2024.1335061.
• Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal diseaseTalasaz A, Sadeghipour P, Ortega-Paz L, Kakavand H, Aghakouchakzadeh M, Beavers C, Fanikos J, Eikelboom J, Siegal D, Monreal M, Jimenez D, Vaduganathan M, Castellucci L, Cuker A, Barnes G, Connors J, Secemsky E, Van Tassell B, De Caterina R, Kurlander J, Aminian A, Piazza G, Goldhaber S, Moores L, Middeldorp S, Kirtane A, Elkind M, Angiolillo D, Konstantinides S, Lip G, Stone G, Cushman M, Krumholz H, Mehran R, Bhatt D, Bikdeli B. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. Nature Reviews Cardiology 2024, 1-19. PMID: 38509244, DOI: 10.1038/s41569-024-01003-3.
• Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic StrategiesAggarwal A, Stolear A, Alam M, Vardhan S, Dulgher M, Jang S, Zarich S. Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies. Journal Of Clinical Medicine 2024, 13: 1781. PMID: 38542006, PMCID: PMC10971616, DOI: 10.3390/jcm13061781.
• Cost-effectiveness of rapid versus in-house versus send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpuraAllen C, Ito S, Butt A, Purcell A, Richmond R, Tormey C, Krumholz H, Cuker A, Goshua G. Cost-effectiveness of rapid versus in-house versus send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura. Blood Advances 2024 PMID: 38502197, DOI: 10.1182/bloodadvances.2024012608.
• Summertime for Cardiovascular AIKhera R, Wiens J. Summertime for Cardiovascular AI. Circulation Cardiovascular Quality And Outcomes 2024, 17: e010404. PMID: 38502717, DOI: 10.1161/circoutcomes.123.010404.
• Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC‐1 study designGroarke J, Crawford J, Collins S, Lubaczewski S, Breen D, Harrington M, Jacobs I, Qiu R, Revkin J, Rossulek M, Saxena A. Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC‐1 study design. Journal Of Cachexia Sarcopenia And Muscle 2024 PMID: 38500292, DOI: 10.1002/jcsm.13435.
• Factors Associated with Long COVID: Insights from Two Nationwide SurveysWu Y, Sawano M, Wu Y, Shah R, Bishop P, Iwasaki A, Krumholz H. Factors Associated with Long COVID: Insights from Two Nationwide Surveys. The American Journal Of Medicine 2024 PMID: 38490304, DOI: 10.1016/j.amjmed.2024.02.032.
• The salt paradox in heart failureCox Z, Testani J. The salt paradox in heart failure. European Journal Of Heart Failure 2024 PMID: 38467462, DOI: 10.1002/ejhf.3194.
• Need for a Cardiogenic Shock Team Collaborative—Promoting a Team‐Based Model of Care to Improve Outcomes and Identify Best PracticesSenman B, Jentzer J, Barnett C, Bartos J, Berg D, Chih S, Drakos S, Dudzinski D, Elliott A, Gage A, Horowitz J, Miller P, Sinha S, Tehrani B, Yuriditsky E, Vallabhajosyula S, Katz J. Need for a Cardiogenic Shock Team Collaborative—Promoting a Team‐Based Model of Care to Improve Outcomes and Identify Best Practices. Journal Of The American Heart Association 2024, 13: e031979. PMID: 38456417, PMCID: PMC11009990, DOI: 10.1161/jaha.123.031979.
• Impact of cardiac size on diagnostic performance of single-photon emission computed tomography myocardial perfusion imaging: insights from the REgistry of Fast Myocardial Perfusion Imaging with NExt generation single-photon emission computed tomographyRandazzo M, Elias P, Poterucha T, Sharir T, Fish M, Ruddy T, Kaufmann P, Sinusas A, Miller E, Bateman T, Dorbala S, Di Carli M, Castillo M, Liang J, Miller R, Dey D, Berman D, Slomka P, Einstein A. Impact of cardiac size on diagnostic performance of single-photon emission computed tomography myocardial perfusion imaging: insights from the REgistry of Fast Myocardial Perfusion Imaging with NExt generation single-photon emission computed tomography. European Heart Journal - Cardiovascular Imaging 2024, jeae055. PMID: 38445511, DOI: 10.1093/ehjci/jeae055.
• AI-Defined Cardiac Anatomy Improves Risk Stratification of Hybrid Perfusion ImagingMiller R, Shanbhag A, Killekar A, Lemley M, Bednarski B, Kavanagh P, Feher A, Miller E, Bateman T, Builoff V, Liang J, Newby D, Dey D, Berman D, Slomka P. AI-Defined Cardiac Anatomy Improves Risk Stratification of Hybrid Perfusion Imaging. JACC Cardiovascular Imaging 2024 PMID: 38456877, DOI: 10.1016/j.jcmg.2024.01.006.
• VEGF-C prophylaxis favors lymphatic drainage and modulates neuroinflammation in a stroke modelBoisserand L, Geraldo L, Bouchart J, Kamouh M, Lee S, Sanganahalli B, Spajer M, Zhang S, Lee S, Parent M, Xue Y, Skarica M, Yin X, Guegan J, Boyé K, Leser F, Jacob L, Poulet M, Li M, Liu X, Velazquez S, Singhabahu R, Robinson M, Askenase M, Osherov A, Sestan N, Zhou J, Alitalo K, Song E, Eichmann A, Sansing L, Benveniste H, Hyder F, Thomas J. VEGF-C prophylaxis favors lymphatic drainage and modulates neuroinflammation in a stroke model. Journal Of Experimental Medicine 2024, 221: e20221983. PMID: 38442272, PMCID: PMC10913814, DOI: 10.1084/jem.20221983.
• Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular DiseaseKayani T, Ahmad B, Chang R, Qian F, Sahinoz M, Rehan M, Giaimo A, Spatz E, Hu J. Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease. Pharmacoepidemiology 2024, 3: 117-168. DOI: 10.3390/pharma3010009.
• Leveraging the Full Potential of Wearable Devices in CardiomyopathiesOikonomou E, Khera R. Leveraging the Full Potential of Wearable Devices in Cardiomyopathies. Journal Of Cardiac Failure 2024 PMID: 38452997, DOI: 10.1016/j.cardfail.2024.02.011.
• Burden of Ischemic and Hemorrhagic Stroke Across the US From 1990 to 2019Renedo D, Acosta J, Leasure A, Sharma R, Krumholz H, de Havenon A, Alahdab F, Aravkin A, Aryan Z, Bärnighausen T, Basu S, Burkart K, Coberly K, Criqui M, Dai X, Desai R, Dharmaratne S, Doshi R, Elgendy I, Feigin V, Filip I, Gad M, Ghozy S, Hafezi-Nejad N, Kalani R, Karaye I, Kisa A, Krishnamoorthy V, Lo W, Mestrovic T, Miller T, Misganaw A, Mokdad A, Murray C, Natto Z, Radfar A, Ram P, Roth G, Seylani A, Shah N, Sharma P, Sheikh A, Singh J, Song S, Sotoudeh H, Vervoort D, Wang C, Xiao H, Xu S, Zand R, Falcone G, Sheth K. Burden of Ischemic and Hemorrhagic Stroke Across the US From 1990 to 2019. JAMA Neurology 2024, 81: 394-404. PMID: 38436973, PMCID: PMC10913004, DOI: 10.1001/jamaneurol.2024.0190.
• Enrollment in High-Deductible Health Plans and Incident Diabetes ComplicationsMcCoy R, Swarna K, Jiang D, Van Houten H, Chen J, Davis E, Herrin J. Enrollment in High-Deductible Health Plans and Incident Diabetes Complications. JAMA Network Open 2024, 7: e243394. PMID: 38517436, PMCID: PMC10960199, DOI: 10.1001/jamanetworkopen.2024.3394.
• Complementary and Inducible creERT2 Mouse Models for Functional Evaluation of Endothelial Cell Subtypes in the Bone MarrowPoulos M, Ramalingam P, Winiarski A, Gutkin M, Katsnelson L, Carter C, Pibouin-Fragner L, Eichmann A, Thomas J, Miquerol L, Butler J. Complementary and Inducible creERT2 Mouse Models for Functional Evaluation of Endothelial Cell Subtypes in the Bone Marrow. Stem Cell Reviews And Reports 2024, 1-15. PMID: 38438768, DOI: 10.1007/s12015-024-10703-9.
• Epidemiology and risk factors for hyperkalaemia in heart failureGrobbee D, Filippatos G, Desai N, Coats A, Pinto F, Rosano G, Cleland J, Kammerer J, de Arellano A. Epidemiology and risk factors for hyperkalaemia in heart failure. ESC Heart Failure 2024 PMID: 38439165, DOI: 10.1002/ehf2.14661.
• Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HFKapelios C, Greene S, Mentz R, Ikeaba U, Wojdyla D, Anstrom K, Eisenstein E, Pitt B, Velazquez E, Fang J, Investigators T. Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HF. Circulation Heart Failure 2024, 17: e011246. PMID: 38436075, PMCID: PMC10950535, DOI: 10.1161/circheartfailure.123.011246.
• Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.Park DY, Hu JR, Jamil Y, Kelsey MD, Jones WS, Frampton J, Kochar A, Aronow WS, Damluji AA, Nanna MG. Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. JAMA Netw Open 2024, 7: e244000. PMID: 38546647, DOI: 10.1001/jamanetworkopen.2024.4000.
• Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis.Stone GW, Christiansen EH, Ali ZA, Andreasen LN, Maehara A, Ahmad Y, Landmesser U, Holm NR. Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis. Lancet 2024, 403: 824-837. PMID: 38401549, DOI: 10.1016/S0140-6736(23)02454-6.
• Devices and Athletics Decision-Making Around Return to PlayKay B, Lampert R. Devices and Athletics Decision-Making Around Return to Play. Cardiac Electrophysiology Clinics 2024, 16: 81-92. PMID: 38280816, DOI: 10.1016/j.ccep.2023.09.009.
• Disruption of the Uty epigenetic regulator locus in hematopoietic cells phenocopies the profibrotic attributes of Y chromosome loss in heart failureHoritani K, Chavkin N, Arai Y, Wang Y, Ogawa H, Yura Y, Evans M, Cochran J, Thel M, Polizio A, Sano M, Miura-Yura E, Arai Y, Doviak H, Arnold A, Gelfand B, Hirschi K, Sano S, Walsh K. Disruption of the Uty epigenetic regulator locus in hematopoietic cells phenocopies the profibrotic attributes of Y chromosome loss in heart failure. Nature Cardiovascular Research 2024, 3: 343-355. DOI: 10.1038/s44161-024-00441-z.
• Inter-Rater Reliability for the Amputation Endpoint in the National Vascular Quality InitiativeSmolderen K, Romain G, Scierka L, Cleman J, Rahman M, Siddiqui W, Lau F, Mao J, Akhlaghi N, Higaki A, Fowler X, Carroll M, Telma K, Alvermann T, Baribeau V, Goodney P, Mena-Hurtado C. Inter-Rater Reliability for the Amputation Endpoint in the National Vascular Quality Initiative. JACC Cardiovascular Interventions 2024, 17: 622-631. PMID: 38479964, DOI: 10.1016/j.jcin.2024.01.003.
• Reply Ethical and Moral Complexities of Left Ventricular Assist Device Deactivation: Embracing the UncertaintyZaidi D, Kirkpatrick J, Fedson S, Hull S. Reply Ethical and Moral Complexities of Left Ventricular Assist Device Deactivation: Embracing the Uncertainty. JACC Heart Failure 2024, 12: 600. PMID: 38448155, DOI: 10.1016/j.jchf.2023.12.020.
• Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registryEl-Chami M, Garweg C, Clementy N, Al-Samadi F, Iacopino S, Martinez-Sande J, Roberts P, Tondo C, Johansen J, Vinolas-Prat X, Cha Y, Grubman E, Bordachar P, Stromberg K, Fagan D, Piccini J. Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry. European Heart Journal 2024, 45: 1241-1251. PMID: 38426911, PMCID: PMC10998730, DOI: 10.1093/eurheartj/ehae101.
• Comparison of Different Durations of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysisPark D, Hu J, Campbell G, Goldwag K, Kelsey M, Altin S, Gallegos-Kattán C, Nanna M. Comparison of Different Durations of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 101859. DOI: 10.1016/j.jscai.2024.101859.
• Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved IndicationsRashedi S, Greason C, Sadeghipour P, Talasaz A, O'Donoghue M, Jimenez D, Monreal M, Anderson C, Elkind M, Kreuziger L, Lang I, Goldhaber S, Konstantinides S, Piazza G, Krumholz H, Braunwald E, Bikdeli B. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications. Seminars In Thrombosis And Hemostasis 2024 PMID: 38428841, DOI: 10.1055/s-0044-1781451.
• Are Cardiac Myosin Inhibitors Useful in Patients With Hypertrophic Obstructive Cardiomyopathy and Comorbid Hypertension? ∗Sikand N, Sen S. Are Cardiac Myosin Inhibitors Useful in Patients With Hypertrophic Obstructive Cardiomyopathy and Comorbid Hypertension? ∗. JACC Heart Failure 2024, 12: 580-582. PMID: 38448152, DOI: 10.1016/j.jchf.2023.12.021.
• Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart FailureMorrow D, Velazquez E, Desai A, DeVore A, Lepage S, Park J, Sharma K, Solomon S, Starling R, Ward J, Williamson K, Zieroth S, Hernandez A, Mentz R, Braunwald E. Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure. Journal Of The American College Of Cardiology 2024, 83: 1123-1132. PMID: 38508844, DOI: 10.1016/j.jacc.2024.01.027.
• Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac HypertrophyLiu X, Li B, Wang S, Zhang E, Schultz M, Touma M, Da Rocha A, Evans S, Eichmann A, Herron T, Chen R, Xiong D, Jaworski A, Weiss S, Si M. Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy. Circulation Research 2024, 134: 913-930. PMID: 38414132, PMCID: PMC10977056, DOI: 10.1161/circresaha.122.321292.
• Heart failure with mildly reduced and preserved ejection fraction: A review of disease burden and remaining unmet medical needs within a new treatment landscapeDesai N, Olewinska E, Famulska A, Remuzat C, Francois C, Folkerts K. Heart failure with mildly reduced and preserved ejection fraction: A review of disease burden and remaining unmet medical needs within a new treatment landscape. Heart Failure Reviews 2024, 1-32. PMID: 38411769, DOI: 10.1007/s10741-024-10385-y.
• Strengthening the Pillars of Cardiovascular Health: Psychological Health is a Crucial ComponentGaffey A, Rollman B, Burg M. Strengthening the Pillars of Cardiovascular Health: Psychological Health is a Crucial Component. Circulation 2024, 149: 641-643. PMID: 38408143, PMCID: PMC10924771, DOI: 10.1161/circulationaha.123.066132.
• Clinical Interpretation of Serum Troponin in the Era of High-Sensitivity TestingMaayah M, Grubman S, Allen S, Ye Z, Park D, Vemmou E, Gokhan I, Sun W, Possick S, Kwan J, Gandhi P, Hu J. Clinical Interpretation of Serum Troponin in the Era of High-Sensitivity Testing. Diagnostics 2024, 14: 503. PMID: 38472975, PMCID: PMC10930800, DOI: 10.3390/diagnostics14050503.
• Female adolescents’ early life stress and body mass index: Differential effects of anger and anxiety in response to rejectionLee S, Jao N, Gaffey A, Reid B, Vergara‐Lopez C, Bublitz M, Stroud L. Female adolescents’ early life stress and body mass index: Differential effects of anger and anxiety in response to rejection. Journal Of Adolescence 2024 PMID: 38402417, DOI: 10.1002/jad.12302.
• Implementing Formal Mitral Heart Team Improves Multidisciplinary Evaluation Rate and Survival of Patients With Severe Primary Mitral Regurgitation.Waldron C, Mori M, Krane M, Reinhardt S, Ahmad Y, Kaple R, Forrest J, Geirsson A. Implementing Formal Mitral Heart Team Improves Multidisciplinary Evaluation Rate and Survival of Patients With Severe Primary Mitral Regurgitation. Journal Of The American Heart Association 2024, e033324. PMID: 38390804, DOI: 10.1161/jaha.123.033324.
• Impact of comorbid opioid use disorder and major depressive disorder on healthcare utilization outcomes in patients with peripheral artery disease: A National Readmission Database analysisAmenyedor K, Lee M, Algara M, Siddiqui W, Hardt M, Romain G, Mena-Hurtado C, Smolderen K. Impact of comorbid opioid use disorder and major depressive disorder on healthcare utilization outcomes in patients with peripheral artery disease: A National Readmission Database analysis. Vascular Medicine 2024, 29: 163-171. PMID: 38391134, DOI: 10.1177/1358863x241228540.
• Predicting Major Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage OcclusionFaridi K, Ong E, Zimmerman S, Varosy P, Friedman D, Hsu J, Kusumoto F, Mortazavi B, Minges K, Pereira L, Lakkireddy D, Koutras C, Denton B, Mobayed J, Curtis J, Freeman J. Predicting Major Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage Occlusion. Circulation Arrhythmia And Electrophysiology 2024, 17: e012424. PMID: 38390713, DOI: 10.1161/circep.123.012424.
• Household food insecurity is associated with greater autonomic dysfunction testing score in Latinos with type 2 diabetesBermúdez-Millán A, Feinn R, Lampert R, Pérez-Escamilla R, Segura-Pérez S, Wagner J. Household food insecurity is associated with greater autonomic dysfunction testing score in Latinos with type 2 diabetes. PLOS ONE 2024, 19: e0297681. PMID: 38394186, PMCID: PMC10889858, DOI: 10.1371/journal.pone.0297681.
• Heterogeneity in the Prognosis of Acute Kidney Injury Following Percutaneous Coronary InterventionHu J, Murugiah K, Xin X, Sawano M, Lu Y, Wilson F, Masoudi F, Messenger J, Krumholz H, Huang C. Heterogeneity in the Prognosis of Acute Kidney Injury Following Percutaneous Coronary Intervention. Journal Of The American Heart Association 2024, 13: e033649. PMID: 38390832, PMCID: PMC10944032, DOI: 10.1161/jaha.123.033649.
• Role of Cardiac MRI in Pericardial DiseasesAnthony C, Akintoye E, Wang T, Klein A. Role of Cardiac MRI in Pericardial Diseases. Current Cardiovascular Imaging Reports 2024, 17: 43-51. DOI: 10.1007/s12410-024-09591-x.
• Disparities in Acute and Chronic Complications of Diabetes Along the U.S. Rural-Urban Continuum.Steiger K, Herrin J, Swarna K, Davis E, McCoy R. Disparities in Acute and Chronic Complications of Diabetes Along the U.S. Rural-Urban Continuum. Diabetes Care 2024 PMID: 38387066, DOI: 10.2337/dc23-1552.
• A new year’s resolution to resolve atrial fibrillation: Resolvin D1 emerges as a powerful target against post-MI atrial remodellingVelasco J, Akar F. A new year’s resolution to resolve atrial fibrillation: Resolvin D1 emerges as a powerful target against post-MI atrial remodelling. Cardiovascular Research 2024, 120: 329-330. PMID: 38387430, PMCID: PMC10981522, DOI: 10.1093/cvr/cvae039.
• Total-Body PET/CT Applications in Cardiovascular Diseases: A Perspective Document of the SNMMI Cardiovascular CouncilSlart R, Bengel F, Akincioglu C, Bourque J, Chen W, Dweck M, Hacker M, Malhotra S, Miller E, Pelletier-Galarneau M, Packard R, Schindler T, Weinberg R, Saraste A, Slomka P. Total-Body PET/CT Applications in Cardiovascular Diseases: A Perspective Document of the SNMMI Cardiovascular Council. Journal Of Nuclear Medicine 2024, 65: jnumed.123.266858. PMID: 38388512, DOI: 10.2967/jnumed.123.266858.
• Multimodality Cardiac Imaging and the Imaging Workforce in the United States: Diversity, Disparities, and Future DirectionsBullock-Palmer R, Rosario K, Douglas P, Hahn R, Lang R, Chareonthaitawee P, Srichai M, Ordovas K, Baldassarre L, Burroughs M, Henderson C, Woodard P, Pressoir K, Swaminathan M, Blankstein R, Daubert M. Multimodality Cardiac Imaging and the Imaging Workforce in the United States: Diversity, Disparities, and Future Directions. Circulation Cardiovascular Imaging 2024, 17: e016409. PMID: 38377238, DOI: 10.1161/circimaging.123.016409.
• Automated vessel-specific coronary artery calcification quantification with deep learning in a large multi-centre registryWilliams M, Shanbhag A, Zhou J, Michalowska A, Lemley M, Miller R, Killekar A, Waechter P, Gransar H, Van Kriekinge S, Builoff V, Feher A, Miller E, Bateman T, Dey D, Berman D, Slomka P. Automated vessel-specific coronary artery calcification quantification with deep learning in a large multi-centre registry. European Heart Journal - Cardiovascular Imaging 2024, jeae045. PMID: 38376471, DOI: 10.1093/ehjci/jeae045.
• Addressing Barriers to Entry and Retention of Women in Interventional Vascular Specialties With Proposed Solutions: A Scientific Statement From the American Heart AssociationAltin S, Kwong M, Hamburg N, Creager M, Banerjee S, Oladini L, Schneider M, Ruddy J. Addressing Barriers to Entry and Retention of Women in Interventional Vascular Specialties With Proposed Solutions: A Scientific Statement From the American Heart Association. Circulation 2024, 149: e986-e995. PMID: 38375663, DOI: 10.1161/cir.0000000000001210.
• Secondary interventions following open versus endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trialConte M, Azene E, Doros G, Gasper W, Hamza T, Kashyap V, Guzman R, Mena-Hurtado C, Menard M, Rosenfield K, Rowe V, Strong M, Farber A. Secondary interventions following open versus endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial. Journal Of Vascular Surgery 2024 PMID: 38368997, DOI: 10.1016/j.jvs.2024.02.005.
• Role of Cognitive Frailty in Older Adults With Cardiovascular DiseaseIjaz N, Jamil Y, Brown C, Krishnaswami A, Orkaby A, Stimmel M, Gerstenblith G, Nanna M, Damluji A. Role of Cognitive Frailty in Older Adults With Cardiovascular Disease. Journal Of The American Heart Association 2024, 13: e033594. PMID: 38353229, PMCID: PMC11010094, DOI: 10.1161/jaha.123.033594.
• Long-Term Percutaneous Coronary Intervention Outcomes in Chronic Versus Acute Coronary Syndromes (TARGET All Comers Trial)Patel K, Lansky A, Kelbæk H, Xu B, van Royen N, Johnson T, Anderson R, Wijns W, Baumbach A, Investigators T. Long-Term Percutaneous Coronary Intervention Outcomes in Chronic Versus Acute Coronary Syndromes (TARGET All Comers Trial). The American Journal Of Cardiology 2024, 217: 94-101. PMID: 38350507, DOI: 10.1016/j.amjcard.2023.12.002.
• Heterogeneity of hepatocyte dynamics restores liver architecture after chemical, physical or viral damageRuz-Maldonado I, Gonzalez J, Zhang H, Sun J, Bort A, Kabir I, Kibbey R, Suárez Y, Greif D, Fernández-Hernando C. Heterogeneity of hepatocyte dynamics restores liver architecture after chemical, physical or viral damage. Nature Communications 2024, 15: 1247. PMID: 38341404, PMCID: PMC10858916, DOI: 10.1038/s41467-024-45439-0.
• Evaluation of short-term mortality in patients with Medicare undergoing endovascular interventions for chronic limb-threatening ischemiaCleman J, Romain G, Callegari S, Scierka L, Jacque F, Smolderen K, Mena-Hurtado C. Evaluation of short-term mortality in patients with Medicare undergoing endovascular interventions for chronic limb-threatening ischemia. Vascular Medicine 2024, 29: 172-181. PMID: 38334045, DOI: 10.1177/1358863x231224335.
• Clinical Biochemistry of Serum TroponinGokhan I, Dong W, Grubman D, Mezue K, Yang D, Wang Y, Gandhi P, Kwan J, Hu J. Clinical Biochemistry of Serum Troponin. Diagnostics 2024, 14: 378. PMID: 38396417, PMCID: PMC10887818, DOI: 10.3390/diagnostics14040378.
• Factors associated with reporting left ventricular ejection fraction with 3D echocardiography in real‐world practiceFaridi K, Zhu Z, Shah N, Crandall I, McNamara R, Flueckiger P, Bachand K, Lombo B, Hur D, Agarwal V, Reinhardt S, Velazquez E, Sugeng L. Factors associated with reporting left ventricular ejection fraction with 3D echocardiography in real‐world practice. Echocardiography 2024, 41: e15774. PMID: 38329886, DOI: 10.1111/echo.15774.
• Digital Health Interventions for Hypertension Management in US Populations Experiencing Health DisparitiesKatz M, Mszar R, Grimshaw A, Gunderson C, Onuma O, Lu Y, Spatz E. Digital Health Interventions for Hypertension Management in US Populations Experiencing Health Disparities. JAMA Network Open 2024, 7: e2356070. PMID: 38353950, PMCID: PMC10867699, DOI: 10.1001/jamanetworkopen.2023.56070.
• Safety of Sports for Patients with Subcutaneous Implantable Cardioverter Defibrillator (SPORT S-ICD): study rationale and protocolChorin E, Lampert R, Bijsterveld N, Knops R, Wilde A, Heidbuchel H, Krahn A, Goldenberg I, Rosso R, Viskin D, Frydman S, Lupu L, Viskin S. Safety of Sports for Patients with Subcutaneous Implantable Cardioverter Defibrillator (SPORT S-ICD): study rationale and protocol. Heart Rhythm O2 2024, 5: 182-188. PMID: 38560377, PMCID: PMC10980925, DOI: 10.1016/j.hroo.2024.01.007.
• AI-derived epicardial fat measurements improve cardiovascular risk prediction from myocardial perfusion imagingMiller R, Shanbhag A, Killekar A, Lemley M, Bednarski B, Van Kriekinge S, Kavanagh P, Feher A, Miller E, Einstein A, Ruddy T, Liang J, Builoff V, Berman D, Dey D, Slomka P. AI-derived epicardial fat measurements improve cardiovascular risk prediction from myocardial perfusion imaging. Npj Digital Medicine 2024, 7: 24. PMID: 38310123, PMCID: PMC10838293, DOI: 10.1038/s41746-024-01020-z.
• Healthy immigrant community study protocol: A randomized controlled trial of a social network intervention for cardiovascular risk reduction among Hispanic and Somali adultsWieland M, Molina L, Goodson M, Capetillo G, Osman A, Ahmed Y, Elmi H, Nur O, Iteghete S, Torres-Herbeck G, Dirie H, Clark M, Lohr A, Smith K, Zeratsky K, Rieck T, Herrin J, Valente T, Sia I. Healthy immigrant community study protocol: A randomized controlled trial of a social network intervention for cardiovascular risk reduction among Hispanic and Somali adults. Contemporary Clinical Trials 2024, 138: 107465. PMID: 38309526, PMCID: PMC10923143, DOI: 10.1016/j.cct.2024.107465.
• The ability of contemporary cardiologists to judge the ischemic impact of a coronary lesion visually.Foley M, Rajkumar CA, Ahmed-Jushuf F, Nour D, Fung CH, Seligman H, Pathimagaraj RH, Petraco R, Sen S, Nijjer S, Howard JP, Ahmad Y, Allahwala U, Bhindi R, Chamie D, Doi S, Kuwata S, Kaihara T, Koga M, Ishibashi Y, Higuma T, Tanabe Y, Nakayama M, Kawase Y, Watanabe A, Funayama N, Horinaka R, Hijikata N, Takahashi T, Matsuo H, Hansen PS, Manica A, Weaver J, Alzuhairi K, Yong TH, Warisawa T, Francis DP, Shun-Shin MJ, Al-Lamee RK. The ability of contemporary cardiologists to judge the ischemic impact of a coronary lesion visually. Cardiovasc Revasc Med 2024, 59: 60-66. PMID: 37612169, DOI: 10.1016/j.carrev.2023.08.003.
• Abstract TP103: Association Between Neighborhood-Level Disadvantage and Patient-Reported Mental Health Outcomes in Intracerebral Hemorrhage SurvivorsTaylor C, Zabinska J, Falcone G, Lalwani D, Peasley E, Sansing L, Arora R, Mena-Hurtado C, Forman R, de Havenon A, Okpala M, Bushnell C, Mullen M, Cohen J, Cohen D, Messe S, Sheth K. Abstract TP103: Association Between Neighborhood-Level Disadvantage and Patient-Reported Mental Health Outcomes in Intracerebral Hemorrhage Survivors. Stroke 2024, 55 DOI: 10.1161/str.55.suppl_1.tp103.
• Contractile phenotypes of engineered heart tissues derived from hypertrophic cardiomyopathy patients lacking sarcomeric mutationsRasheed Y, Young S, Halder S, Li X, Stendahl J, Campbell S. Contractile phenotypes of engineered heart tissues derived from hypertrophic cardiomyopathy patients lacking sarcomeric mutations. Biophysical Journal 2024, 123: 388a. DOI: 10.1016/j.bpj.2023.11.2357.
• Insulin Requirement and Infrainguinal Bypass Outcomes in Patients with Peripheral Arterial DiseaseAlameddine D, Satam K, Slade M, Wang H, Mena-Hurtado C, Turner J, Inzucchi S, Ochoa Chaar C. Insulin Requirement and Infrainguinal Bypass Outcomes in Patients with Peripheral Arterial Disease. Annals Of Vascular Surgery 2024, 102: 25-34. PMID: 38307234, DOI: 10.1016/j.avsg.2023.11.044.
• Variability in guideline-directed medical therapy across sites and operators and long-term mortality and amputation outcomes risk in patients undergoing peripheral vascular interventionsSmolderen K, Romain G, Cleman J, Scierka L, Mena-Hurtado C. Variability in guideline-directed medical therapy across sites and operators and long-term mortality and amputation outcomes risk in patients undergoing peripheral vascular interventions. American Heart Journal 2024, 270: 75-85. PMID: 38307364, DOI: 10.1016/j.ahj.2024.01.008.
• ReplyCleman J, Romain G, Smolderen K, Mena-Hurtado C. Reply. Journal Of Vascular Surgery 2024, 79: 456. PMID: 38245191, DOI: 10.1016/j.jvs.2023.11.001.
• Use of a Single-Item Ecological Momentary Assessment to Measure Daily Exercise: Agreement with Accelerometer-Measured ExerciseSundquist K, Schwartz J, Burg M, Davidson K, Diaz K. Use of a Single-Item Ecological Momentary Assessment to Measure Daily Exercise: Agreement with Accelerometer-Measured Exercise. Sensors 2024, 24: 946. PMID: 38339663, PMCID: PMC10857316, DOI: 10.3390/s24030946.
• Sex-specific analysis of intravascular lithotripsy for peripheral artery disease from the Disrupt PAD III observational studyNagpal S, Altin S, McGinigle K, Mangalmurti S, Adams G, Shammas N, Mehrle A, Soukas P, Bertolet B, Lansky A. Sex-specific analysis of intravascular lithotripsy for peripheral artery disease from the Disrupt PAD III observational study. European Journal Of Vascular And Endovascular Surgery 2024, 67: e22-e23. DOI: 10.1016/j.ejvs.2024.01.026.
• Sports Participation by Athletes With Cardiovascular DiseaseMartinez M, Ackerman M, Annas G, Baggish A, Day S, Harmon K, Kim J, Levine B, Putukian M, Lampert R. Sports Participation by Athletes With Cardiovascular Disease. Journal Of The American College Of Cardiology 2024, 83: 865-868. PMID: 38383101, DOI: 10.1016/j.jacc.2023.12.021.
• Top Stories: Mitochondrial origin of inherited cardiac arrhythmiasAkar F, Maack C. Top Stories: Mitochondrial origin of inherited cardiac arrhythmias. Heart Rhythm 2024, 21: 235-236. PMID: 38296456, PMCID: PMC10857749, DOI: 10.1016/j.hrthm.2023.10.020.
• 800.09 Surgical Risk Does Not Predict Ischemic Stroke or Acute Infarction After TAVR: Results of a Patient-Level Pooled AnalysisGrubman D, Lansky A, Dwyer M, Zivadinov R, Pietras C, Nazif T, Moses J, Shah T, Gambone L, Leon M, Forrest J, Vora A, Parise H, Messé S. 800.09 Surgical Risk Does Not Predict Ischemic Stroke or Acute Infarction After TAVR: Results of a Patient-Level Pooled Analysis. JACC Cardiovascular Interventions 2024, 17: s67-s68. DOI: 10.1016/j.jcin.2024.01.234.
• 100.58 Intravascular Imaging or Angiographic Guidance in Patients Undergoing Impella-Supported High-Risk Percutaneous Coronary InterventionAbu-Much A, Bonnet G, Zhao D, Wollmuth J, Thompson J, Moses J, Redfors B, Bharadwaj A, Lansky A, Falah B, Cohen D, Truesdell A, O'Neill W. 100.58 Intravascular Imaging or Angiographic Guidance in Patients Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention. JACC Cardiovascular Interventions 2024, 17: s16. DOI: 10.1016/j.jcin.2024.01.111.
• 100.63 In-Hospital Safety and Effectiveness of Non-Emergent, MCS-Supported High-Risk PCI Procedures: A Comprehensive Propensity-Score Matched Analysis of Contemporary, Large-Scale Claims DatasetO'Neill W, Shah T, Holy C, Coplan P, Almedhychy A, Moses J, Parise H, Lansky A. 100.63 In-Hospital Safety and Effectiveness of Non-Emergent, MCS-Supported High-Risk PCI Procedures: A Comprehensive Propensity-Score Matched Analysis of Contemporary, Large-Scale Claims Dataset. JACC Cardiovascular Interventions 2024, 17: s18. DOI: 10.1016/j.jcin.2024.01.116.
• 800.01 Redo-TAVR with the Supra-Annular, Self-Expanding Evolut Platform: Insights from a Multi-Center Real-World RegistryRogers T, Bapat V, Chetcuti S, Dauerman H, Forrest J, Grubb K, Htun W, Puri R, Reardon M, Tang G, Vora A, Yakubov S, Eisenberg R, Attizzani G. 800.01 Redo-TAVR with the Supra-Annular, Self-Expanding Evolut Platform: Insights from a Multi-Center Real-World Registry. JACC Cardiovascular Interventions 2024, 17: s65. DOI: 10.1016/j.jcin.2024.01.227.
• A BAYESIAN MACHINE LEARNING APPROACH FOR ESTIMATING HETEROGENEOUS SURVIVOR CAUSAL EFFECTS: APPLICATIONS TO A CRITICAL CARE TRIAL.Chen X, Harhay M, Tong G, Li F. A BAYESIAN MACHINE LEARNING APPROACH FOR ESTIMATING HETEROGENEOUS SURVIVOR CAUSAL EFFECTS: APPLICATIONS TO A CRITICAL CARE TRIAL. The Annals Of Applied Statistics 2024, 18: 350-374. PMID: 38455841, PMCID: PMC10919396, DOI: 10.1214/23-aoas1792.
• Treatment of Acute Myocardial Infarction and Cardiogenic Shock: Outcomes of the RECOVER III Postapproval Study by Society of Cardiovascular Angiography and Interventions Shock Stage.Hanson I, Rusia A, Palomo A, Tawney A, Pow T, Dixon S, Meraj P, Sievers E, Johnson M, Wohns D, Ali O, Kapur N, Grines C, Burkhoff D, Anderson M, Lansky A, Naidu S, Basir M, O'Neill W. Treatment of Acute Myocardial Infarction and Cardiogenic Shock: Outcomes of the RECOVER III Postapproval Study by Society of Cardiovascular Angiography and Interventions Shock Stage. Journal Of The American Heart Association 2024, 13: e031803. PMID: 38293995, DOI: 10.1161/jaha.123.031803.
• Complex Congenital Heart Disease in the AdultGoldstein S, Krasuski R. Complex Congenital Heart Disease in the Adult. Annual Review Of Medicine 2024, 75: 493-512. PMID: 38285514, DOI: 10.1146/annurev-med-050922-052324.
• Association of marital/partner status with hospital readmission among young adults with acute myocardial infarction.Zhu C, Dreyer R, Li F, Spatz E, Caraballo C, Mahajan S, Raparelli V, Leifheit E, Lu Y, Krumholz H, Spertus J, D'Onofrio G, Pilote L, Lichtman J. Association of marital/partner status with hospital readmission among young adults with acute myocardial infarction. PLOS ONE 2024, 19: e0287949. PMID: 38277368, PMCID: PMC10817183, DOI: 10.1371/journal.pone.0287949.
• Decreasing alloimmunization‐specific mortality in sickle cell disease in the United States: Cost‐effectiveness of a shared transfusion resourceIto S, Pandya A, Hauser R, Krishnamurti L, Stites E, Tormey C, Krumholz H, Hendrickson J, Goshua G. Decreasing alloimmunization‐specific mortality in sickle cell disease in the United States: Cost‐effectiveness of a shared transfusion resource. American Journal Of Hematology 2024, 99: 570-576. PMID: 38279581, DOI: 10.1002/ajh.27211.
• Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)Mullens W, Dauw J, Gustafsson F, Mebazaa A, Steffel J, Witte K, Delgado V, Linde C, Vernooy K, Anker S, Chioncel O, Milicic D, Hasenfuß G, Ponikowski P, von Bardeleben R, Koehler F, Ruschitzka F, Damman K, Schwammenthal E, Testani J, Zannad F, Böhm M, Cowie M, Dickstein K, Jaarsma T, Filippatos G, Volterrani M, Thum T, Adamopoulos S, Cohen‐Solal A, Moura B, Rakisheva A, Ristic A, Bayes‐Genis A, Van Linthout S, Tocchetti C, Savarese G, Skouri H, Adamo M, Amir O, Yilmaz M, Simpson M, Tokmakova M, González A, Piepoli M, Seferovic P, Metra M, Coats A, Rosano G. Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC). European Journal Of Heart Failure 2024, 26: 483-501. PMID: 38269474, DOI: 10.1002/ejhf.3150.
• Impaired mobility and MRI markers of vascular brain injury: Atherosclerosis Risk in Communities and UK Biobank studiesSharma R, de Havenon A, Rivier C, Payabvash S, Forman R, Krumholz H, Falcone G, Sheth K, Kernan W. Impaired mobility and MRI markers of vascular brain injury: Atherosclerosis Risk in Communities and UK Biobank studies. BMJ Neurology Open 2024, 6: e000501. PMID: 38288313, PMCID: PMC10823923, DOI: 10.1136/bmjno-2023-000501.
• Biometric contrastive learning for data-efficient deep learning from electrocardiographic imagesSangha V, Khunte A, Holste G, Mortazavi B, Wang Z, Oikonomou E, Khera R. Biometric contrastive learning for data-efficient deep learning from electrocardiographic images. Journal Of The American Medical Informatics Association 2024, 31: 855-865. PMID: 38269618, PMCID: PMC10990541, DOI: 10.1093/jamia/ocae002.
• Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9—Pragmatic Research and Innovation through Multinational ExperimentationOmerovic E, Petrie M, Redfors B, Fremes S, Murphy G, Marquis-Gravel G, Lansky A, Velazquez E, Perera D, Reid C, Smith J, van der Meer P, Lipsic E, Juni P, McMurray J, Bauersachs J, Køber L, Rouleau J, Doenst T. Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9—Pragmatic Research and Innovation through Multinational Experimentation. Trials 2024, 25: 80. PMID: 38263138, PMCID: PMC10807265, DOI: 10.1186/s13063-024-07935-y.
• Psychosocial and Socio-Economic Factors are Most Predictive of Health Status in Patients with ClaudicationScierka L, Peri-Okonny P, Romain G, Cleman J, Spertus J, Fitridge R, Secemsky E, Patel M, Gosch K, Mena-Hurtado C, Smolderen K. Psychosocial and Socio-Economic Factors are Most Predictive of Health Status in Patients with Claudication. Journal Of Vascular Surgery 2024 PMID: 38266885, DOI: 10.1016/j.jvs.2024.01.021.
• Gamma protocadherins in vascular endothelial cells inhibit Klf2/4 to promote atherosclerosis.Joshi D, Coon BG, Chakraborty R, Deng H, Fernandez-Tussy P, Meredith E, Traylor JG, Orr AW, Fernandez-Hernando C, Schwartz MA. Gamma protocadherins in vascular endothelial cells inhibit Klf2/4 to promote atherosclerosis. BioRxiv 2024 PMID: 38293157, DOI: 10.1101/2024.01.16.575958.